Keywords: USA, FDA, Court ruling, Shire, Vyvanse, ADHD, Actavis

US Court upholds FDA’s grant of five-year market exclusivity for Shire’s ADHD drug Vyvanse

Article | 05 March 2010

Print This

The US District Court for the District of Columbia has upheld the Food and Drug Administration’s decision reaffirming that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in